CPIG
KALA icon

Chicago Partners Investment Group’s KALA BIO KALA Stock Holding History

Chicago Partners Investment Group’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11
Closed -$55K – 588
2021
Q3 		$55K Buy
11
+4
+57% +$34.5K ﹤0.01% 574
2021
Q2 		$65K Buy
7
+1
+17% +$15.7K ﹤0.01% 525
2021
Q1 		$124K Hold
6
– – 0.01% 506
2020
Q4 		$114K Buy
+6
New +$113K 0.01% 452

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chicago Partners Investment Group's KALA Position: Q4 2021 in Review

Chicago Partners Investment Group sold out of KALA BIO (KALA) in Q4 2021, closing a stake of 11 shares — an estimated $55K sold.

Chicago Partners Investment Group first reported a position in KALA in Q4 2020 and held it in 4 quarters. The position peaked at $124K in Q1 2021. 79 funds tracked by Wall St. Rank hold KALA as of Q4 2021.

  • Chicago Partners Investment Group reported no remaining KALA BIO position as of Q4 2021 after selling out during the quarter.
  • Chicago Partners Investment Group sold 11 KALA BIO shares in Q4 2021, an estimated $55K.
  • Chicago Partners Investment Group first reported a position in KALA BIO in Q4 2020 and held it in 4 quarters.
  • Chicago Partners Investment Group's KALA BIO position peaked at $124K in Q1 2021.
  • 79 funds tracked by Wall St. Rank held KALA BIO as of Q4 2021.

Based on Chicago Partners Investment Group's 13F filing for Q4 2021, filed 15 Feb 2022.